RESUMO
The biological function of a nonstructural protein, NSm, of Akabane virus (AKAV) is unknown. In this study, we generated a series of NSm deletion mutant viruses by reverse genetics and compared their phenotypes. The mutant in which the NSm coding region was almost completely deleted could not be rescued, suggesting that NSm plays a role in virus replication. We next generated mutant viruses possessing various partial deletions in NSm and identified several regions critical for virus infectivity. All rescued mutant viruses produced smaller plaques and grew inefficiently in cell culture, compared to the wild-type virus. Interestingly, although the pathogenicity of NSm deletion mutant viruses varied in mice depending on their deletion regions and sizes, more than half the mice died following infection with any mutant virus and the dead mice exhibited encephalitis as in wild-type virus-inoculated mice, indicating their neuroinvasiveness. Abundant viral antigens were detected in the brain tissues of dead mice, whereas appreciable antigen was not observed in those of surviving mice, suggesting a correlation between virus growth rate in the brain and neuropathogenicity in mice. We conclude that NSm affects AKAV replication in vitro as well as in vivo and that it may function as a virulence factor.
Assuntos
Infecções por Bunyaviridae/virologia , Orthobunyavirus/crescimento & desenvolvimento , Proteínas não Estruturais Virais/fisiologia , Animais , Encéfalo/patologia , Encéfalo/virologia , Infecções por Bunyaviridae/patologia , Linhagem Celular , Chlorocebus aethiops , Cricetinae , Modelos Animais de Doenças , Camundongos , Camundongos Endogâmicos BALB C , Mutação/genética , Orthobunyavirus/genética , Orthobunyavirus/patogenicidade , Células Vero/virologiaRESUMO
Here, we assessed the sulfated derivative of the microbial polysaccharide gellan gum and derivatives of λ and κ-carrageenans for their ability to inhibit Plasmodium falciparum 3D7 and Dd2 growth and invasion of red blood cells in vitro. Growth inhibition was assessed by means of flow cytometry after a 96-h exposure to the inhibitors and invasion inhibition was assessed by counting ring parasites after a 20-h exposure to them. Gellan sulfate strongly inhibited invasion and modestly inhibited growth for both P. falciparum 3D7 and Dd2; both inhibitory effects exceeded those achieved with native gellan gum. The hydrolyzed λ-carrageenan and oversulfated κ-carrageenan were less inhibitory than their native forms. In vitro cytotoxicity and anticoagulation assays performed to determine the suitability of the modified polysaccharides for in vivo studies showed that our synthesized gellan sulfate had low cytotoxicity and anticoagulant activity.
Assuntos
Malária Falciparum/tratamento farmacológico , Plasmodium falciparum/efeitos dos fármacos , Polissacarídeos/farmacologia , Ésteres do Ácido Sulfúrico/farmacologia , Animais , Eritrócitos/parasitologia , Citometria de Fluxo , Humanos , Técnicas In Vitro , Malária Falciparum/sangue , Malária Falciparum/parasitologia , Plasmodium falciparum/efeitos da radiação , Polissacarídeos/sangue , Ésteres do Ácido Sulfúrico/sangueRESUMO
Heparin, a sulfated glycoconjugate, reportedly inhibits the blood-stage growth of the malaria parasite Plasmodium falciparum. Elucidation of the inhibitory mechanism is valuable for developing novel invasion-blocking treatments based on heparin. Merozoite surface protein 1 has been reported as a candidate target of heparin; however, to better understand the molecular mechanisms involved, we characterized the molecules that bind to heparin during merozoite invasion. Here, we show that heparin binds only at the apical tip of the merozoite surface and that multiple heparin-binding proteins localize preferentially in the apical organelles. To identify heparin-binding proteins, parasite proteins were fractionated by means of heparin affinity chromatography and subjected to immunoblot analysis with ligand-specific antibodies. All tested members of the Duffy and reticulocyte binding-like families bound to heparin with diverse affinities. These findings suggest that heparin masks the apical surface of merozoites and blocks interaction with the erythrocyte membrane after initial attachment.
Assuntos
Heparina/metabolismo , Proteína 1 de Superfície de Merozoito/metabolismo , Plasmodium falciparum/metabolismo , Antígenos de Protozoários/química , Antígenos de Protozoários/metabolismo , Eritrócitos/química , Eritrócitos/metabolismo , Heparina/química , Humanos , Proteínas de Membrana/química , Proteínas de Membrana/metabolismo , Proteína 1 de Superfície de Merozoito/química , Ligação Proteica , Proteínas de Protozoários/química , Proteínas de Protozoários/metabolismo , Receptores Proteína Tirosina Quinases/química , Receptores Proteína Tirosina Quinases/metabolismoRESUMO
Toxoplasma rhoptry neck protein 4 (TgRON4) is a component of the moving junction macromolecular complex that plays a central role during invasion. TgRON4 is exposed on the cytosolic side of the host cell during invasion, but its molecular interactions remain unclear. Here, we identified host cellular ß-tubulin as a binding partner of TgRON4, but not Plasmodium RON4. Coimmunoprecipitation studies in mammalian cells demonstrated that the C-terminal 15-kDa region of ß-tubulin was sufficient for binding to TgRON4, and that a 17-kDa region in the proximal C-terminus of TgRON4 was required for binding to the C-terminal region of ß-tubulin. Analysis of T. gondii-infected lysates from CHO cells expressing the TgRON4-binding region showed that the C-terminal region of ß-tubulin interacted with TgRON4 at early invasion step. Our results provide evidence for a parasite-specific interaction between TgRON4 and the host cell cytoskeleton in parasite-infected cells.
Assuntos
Interações Hospedeiro-Parasita/fisiologia , Peptídeo Hidrolases/metabolismo , Proteínas de Protozoários/metabolismo , Toxoplasma/metabolismo , Tubulina (Proteína)/metabolismo , Animais , Antígenos de Protozoários , Células CHO , Proteínas de Transporte/metabolismo , Células Cultivadas , Cricetinae , Cricetulus , Imunoprecipitação , Proteínas de Membrana/metabolismo , Plasmodium falciparum/metabolismoRESUMO
The cell cycle of Plasmodium is unique among major eukaryotic cell cycle models. Cyclin-dependent kinases (CDKs) are thought to be the key molecular switches that regulate cell cycle progression in the parasite. However, little information is available about Plasmodium CDKs. The present study was performed to investigate the effects of a CDK inhibitor, olomoucine, on the erythrocytic growth of Plasmodium falciparum. This agent inhibited the growth of the parasite at the trophozoite/schizont stage. Furthermore, we characterized the Plasmodium CDK homolog, P. falciparum cdc2-related kinase-1 (Pfcrk-1), which is a potential target of olomoucine. We synthesized a functional kinase domain of Pfcrk-1 as a GST fusion protein using a wheat germ protein expression system, and examined its phosphorylation activity. The activity of this catalytic domain was higher than that of GST-GFP control, but the same as that of a kinase-negative mutant of Pfcrk-1. After the phosphatase treatment, the labeling of [γ-(32)P]ATP was abolished. Recombinant human cyclin proteins were added to these kinase reactions, but there were no differences in activity. This report provides important information for the future investigation of Plasmodium CDKs.
Assuntos
Antimaláricos/farmacologia , Quinases relacionadas a CDC2 e CDC28/metabolismo , Quinases Ciclina-Dependentes/antagonistas & inibidores , Cinetina/farmacologia , Plasmodium falciparum/enzimologia , Quinases relacionadas a CDC2 e CDC28/genética , Células Cultivadas , Eritrócitos/parasitologia , Regulação Enzimológica da Expressão Gênica , HumanosRESUMO
Toxoplasma gondii is an important food and waterborne pathogen that causes severe disease in immunocompromised patients. Bumped kinase inhibitors (BKIs) have an antiparasitic effect on T. gondii tachyzoite growth by targeting T. gondii calmodulin-domain protein kinase 1 (TgCDPK1). To identify mutations that confer resistance to BKIs, chemical mutagenesis was performed, followed by selection in media containing either 250 or 1000 nM 1NM-PP1. Whole-genome sequence analysis of resistant clones revealed single nucleotide mutations in T. gondii mitogen-activated protein kinase 1 (TgMAPK1) at amino acids 162 (L162Q) and 171 (I171N). Plasmid constructs having the TgMAPK1 L162Q mutant sequence successfully replaced native TgMAPK1 genome locus in the presence of 1000 nM 1NM-PP1. The inhibitory effect of 1NM-PP1 on cell division observed in the parent clone was decreased in 1NM-PP1-resistant clones; however, effects on parasite invasion and calcium-induced egress were similar in both parent and resistant clones. A plasmid construct expressing the full length TgMAPK1 splicing isoform with L162Q mutation successfully complemented TgMAPK1 function in the pressure of 250 nM 1NM-PP1 in plaque assay. 1NM-PP1-resistant clones showed resistance to other BKIs (3MB-PP1 and 3BrB-PP1) with different levels. Here we identify TgMAPK1 as a novel target for 1NM-PP1 activity. This inhibitory effect is mediated through inhibition of tachyzoite cell division, and can be overcome through mutations at multiple residues in TgMAPK1.
RESUMO
Inhibitors of cellular protein kinases have been reported to inhibit the development of Apicomplexan parasites, suggesting that the functions of protozoan protein kinases are critical for their life cycle. However, the specific roles of these protein kinases cannot be determined using only these inhibitors without molecular analysis, including gene disruption. In this report, we describe the functions of Apicomplexan protein kinases in each parasite life stage and the potential of pre-existing protein kinase inhibitors as Apicomplexan drugs against, mainly, Plasmodium and Toxoplasma.
Assuntos
Apicomplexa/enzimologia , Estágios do Ciclo de Vida , Inibidores de Proteínas Quinases/farmacologia , Proteínas Quinases/metabolismo , Proteínas de Protozoários/metabolismo , Animais , Apicomplexa/efeitos dos fármacos , Apicomplexa/genética , Apicomplexa/crescimento & desenvolvimento , Plasmodium/efeitos dos fármacos , Plasmodium/enzimologia , Plasmodium/genética , Plasmodium/crescimento & desenvolvimento , Proteínas Quinases/efeitos dos fármacos , Proteínas Quinases/genética , Proteínas de Protozoários/efeitos dos fármacos , Proteínas de Protozoários/genética , Toxoplasma/efeitos dos fármacos , Toxoplasma/enzimologia , Toxoplasma/genética , Toxoplasma/crescimento & desenvolvimentoRESUMO
BACKGROUND: cAMP-dependent protein kinase (PKA) has been implicated in the asexual stage of the Toxoplasma gondii life cycle through assaying the effect of a PKA-specific inhibitor on its growth rate. Since inhibition of the host cell PKA cannot be ruled out, a more precise evaluation of the role of PKA, as well as characterization of the kinase itself, is necessary. METHODOLOGY/PRINCIPAL FINDING: The inhibitory effects of two PKA inhibitors, H89, an ATP-competitive chemical inhibitor, and PKI, a substrate-competitive mammalian natural peptide inhibitor, were estimated. In the in vitro kinase assay, the inhibitory effect of PKI on a recombinant T. gondii PKA catalytic subunit (TgPKA-C) was weaker compared to that on mammalian PKA-C. In a tachyzoite growth assay, PKI had little effect on the growth of tachyzoites, whereas H89 strongly inhibited it. Moreover, T. gondii PKA regulatory subunit (TgPKA-R)-overexpressing tachyzoites showed a significant growth defect. CONCLUSIONS/SIGNIFICANCE: Our data suggest that PKA plays an important role in the growth of tachyzoites, and the inhibitory effect of substrate-competitive inhibitor PKI on T. gondii PKA was low compared to that of the ATP competitive inhibitor H89.
Assuntos
Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Toxoplasma/enzimologia , Toxoplasma/crescimento & desenvolvimento , Trifosfato de Adenosina/metabolismo , Sequência de Aminoácidos , Ligação Competitiva , Domínio Catalítico , Proteínas Quinases Dependentes de AMP Cíclico/antagonistas & inibidores , Proteínas Quinases Dependentes de AMP Cíclico/química , Proteínas Quinases Dependentes de AMP Cíclico/genética , Regulação Enzimológica da Expressão Gênica , Isoquinolinas/farmacologia , Dados de Sequência Molecular , Peptídeos/farmacologia , Inibidores de Proteínas Quinases/farmacologia , Sulfonamidas/farmacologiaRESUMO
Bumped kinase inhibitors (BKIs) target analog-sensitive kinases, which the genomes of mammals rarely encode. Previously, we demonstrated that a BKI effectively suppressed the in vitro replication of Toxoplasma gondii, the causative pathogen of toxoplasmosis, by targeting T. gondii calcium-dependent protein kinase 1 (TgCDPK1) (Eukaryotic Cell, 9: 667-670). Here, we examined whether the BKI 1NM-PP1 reduced parasite replication in vivo. A high dose of 1NM-PP1, by intraperitoneal injection, just before the parasite inoculation effectively reduced the parasite load in the brains, livers, and lungs of T. gondii-infected mice, however, a low dose of 1NM-PP1 with oral administration didn't change the survival rates of infected mice.
Assuntos
Antiprotozoários/uso terapêutico , Inibidores de Proteínas Quinases/uso terapêutico , Pirazóis/uso terapêutico , Pirimidinas/uso terapêutico , Toxoplasmose/tratamento farmacológico , Administração Oral , Animais , Encéfalo/parasitologia , Relação Dose-Resposta a Droga , Feminino , Injeções Intraperitoneais , Fígado/parasitologia , Pulmão/parasitologia , Camundongos , Camundongos Endogâmicos ICR , Carga Parasitária , Taxa de Sobrevida , Toxoplasmose/mortalidade , Toxoplasmose/parasitologiaRESUMO
Pirfenidone (PFD) is focused on a new anti-fibrotic drug, which can minimize lung fibrosis etc. We evaluated the superoxide (O2*-) scavenging activities of PFD and the PFD-iron complex by electron spin resonance (ESR) spectroscopy, luminol-dependent chemiluminescence assay, and cytochrome c reduction assay. Firstly, we confirmed that the PFD-iron complex was formed by mixing iron chloride with threefold molar PFD, and the complex was stable in distilled water and ethanol. Secondary, the PFD-iron complex reduced the amount of O2*- produced by xanthine oxidase/hypoxanthine without inhibiting the enzyme activity. Thirdly, it also reduced the amount of O2*- released from phorbor ester-stimulated human neutrophils. PFD alone showed few such effects. These results suggest the possibility that the O2*- scavenging effect of the PFD-iron complex contributes to the anti-fibrotic action of PFD used for treating idiopathic pulmonary fibrosis.
Assuntos
Sequestradores de Radicais Livres/farmacologia , Piridonas/farmacologia , Superóxidos/metabolismo , Linhagem Celular , Sequestradores de Radicais Livres/síntese química , Sequestradores de Radicais Livres/uso terapêutico , Humanos , Ferro , Neutrófilos/efeitos dos fármacos , Neutrófilos/metabolismo , Fibrose Pulmonar/tratamento farmacológico , Piridonas/química , Piridonas/uso terapêutico , Superóxidos/químicaRESUMO
Electron spin resonance using spin-trapping is a useful technique for detecting direct reactive oxygen species, such as superoxide (O2.-). However, the widely used spin trap 2,2-dimethyl-3,4-dihydro-2H-pyrrole N-oxide (DMPO) has several fundamental limitations in terms of half-life and stability. Recently, the new spin trap 2-diphenylphosphinoyl-2-methyl-3,4-dihydro-2H-pyrrole N-oxide (DPhPMPO) was developed by us. We evaluated the biological applicability of DPhPMPO to analyze O2.- in both cell-free and cellular systems. DPhPMPO had a larger rate constant for O2.- and formed more stable spin adducts for O2.- than DMPO in the xanthine/xanthine oxidase (X/XO) system. In the phorbol myristate acetate-activated neutrophil system, the detection potential of DPhPMPO for O2.- was significantly higher than that of DMPO (k(DMPO)=13.95M(-1)s(-1), k(DPhPMPO)=42.4M(-1)s(-1)). These results indicated that DPhPMPO is a potentially good candidate for trapping O2.- in a biological system.